3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Recruiting
2
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Conditions
Small Cell Lung Carcinoma
15
Lung Neoplasms
5
Neoplasms
4
Sarcoma
3
Sarcoma, Ewing
2
Neuroendocrine Tumors
2
Desmoplastic Small Round Cell Tumor
2
Stomach Neoplasms
1
SCLC, Extensive Stage
1
Platinum-Resistant Lung Small Cell Carcinoma
1
Ovarian Neoplasms
1
Neutropenia
1
Mesothelioma
1
Leiomyosarcoma
1
Glioblastoma
1
Gastrointestinal Malignancies
1
Gastro-enteropancreatic neuroendocrine tumor
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Adenoma, Islet Cell
1
Interventions
Temozolomide
3
Cyclophosphamide
3
fludarabine phosphate
2
Vincristine
2
PM 01183
2
Irinotecan
2
Ifosfamide
2
Etoposide
2
Doxorubicin
2
thymoglobulin
1
temsirolimus
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
fludarabine
1
Zoledronic Acid
1
Vinorelbine
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Stem Cell Transplantation
1
Sorafenib
1
Ramucirumab
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
PM 01183
×
1 year
×
Clear all
NCT07328425
2026-04-03
ISG-TULIPS
Italian Sarcoma Group
Phase 2
Recruiting
20 enrolled
NCT05918640
2026-03-31
LiFFT
Children's Hospital of Philadelphia
Phase 1/2
Recruiting
63 enrolled